has subject area Alzheimer Disease Amyloid beta-Peptides Antibodies, Monoclonal, Humanized Cost-Benefit Analysis Device Approval Direct-to-Consumer Advertising Drug Costs Drug and Narcotic Control Humans Medicare Nootropic Agents United States United States Food and Drug Administration
